Expertise in
28
conditions

Peter Kamenicky

Paris, FR 
Expertise in
28
conditions
Paris, FR 

Overview

Peter Kamenicky practices practicing medicine in Paris, France.

Mr. Kamenicky is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hypophosphatemia, X-Linked Hypophosphatemia, Rickets, Parathyroidectomy, and Endoscopic Transnasal Transsphenoidal Surgery.

He is actively involved in clinical research, co-authoring 128 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Paris, 94275, France
Other Locations
Gif-sur-yvette, 91190, France
Le Kremlin Bicêtre, France
Orsay, France
78 Rue Du Général Leclerc, Rouez, 94270, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
A Phase 3b Open-label Study of the Anti-FGF23 Antibody, Burosumab (KRN23) in Adult Patients With X-linked Hypophosphatemia (XLH)
A Phase 3b Open-label Study of the Anti-FGF23 Antibody, Burosumab (KRN23) in Adult Patients With X-linked Hypophosphatemia (XLH)
Enrollment Status: Completed
Publish Date: May 20, 2022
Intervention Type: Drug
Study Drug: Burosumab
Study Phase: Phase 3
View 1 Less Clinical Trial

128 Total Publications

Preparation for parathyroid surgery.
Preparation for parathyroid surgery.
Journal: Journal of visceral surgery
Published: August 18, 2026

Frequently Asked Questions about Peter Kamenicky

Is Peter Kamenicky a top-rated expert for Hypophosphatemia?

MediFind is an objective health platform that identifies experts based on real-world data. Peter Kamenicky is classified as an Elite expert for Hypophosphatemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter Kamenicky participate in research or clinical trials?

Yes. Peter Kamenicky has published 128 articles and abstracts on conditions like Hypophosphatemia. You can view a list of Peter Kamenicky's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kamenicky's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 14 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile